Virtual Project: Gene Therapy
---
Section 1: Title Slide / Introduction
Title: Gene Therapy: Unlocking the Future of Medicine
Subtitle: A Revolutionary Approach to Treating Genetic Disorders
Your Details: [Your Name], [Your Class/Grade], [Your School Name], [Date]
---
Section 2: Table of Contents / Navigation
1. What is Gene Therapy?
2. The Genetic Foundation
3. How Gene Therapy Works
4. CRISPR: The Game Changer
5. Real-World Impact
6. The Hurdles
7. Beyond the Lab
8. What's Next?
9. Conclusion
10. References
---
Section 3: What is Gene Therapy?
Gene therapy is an innovative medical approach that treats or prevents disease by modifying
genes within a patient’s cells. It aims to correct genetic errors at their source, offering hope
for diseases like cystic fibrosis and some cancers. Originating in the 1970s, human trials
began in the 1990s and have advanced rapidly since.
---
Section 4: The Genetic Foundation
DNA is the body’s instruction manual. Its segments—genes—code for proteins that perform
essential cell functions. Genetic disorders result from mutations in these genes, leading to
faulty or missing proteins. For example, cystic fibrosis results from a mutation in the CFTR
gene.
---
Section 5: How Gene Therapy Works
Gene therapy works by:
Introducing a new gene,
Inactivating a faulty gene,
Or adding a new gene to help fight disease.
Types:
Somatic gene therapy targets body cells (non-inheritable).
Germline therapy targets reproductive cells (inheritable but not used in humans).
Delivery Methods (Vectors):
Viral vectors: Modified viruses like AAVs, retroviruses.
Non-viral methods: Liposomes, direct DNA injection, electroporation.
---
Section 6: In Vivo vs. Ex Vivo
In Vivo: Vector is injected directly into the body. Simpler, but less precise. Ex Vivo: Cells are
modified in a lab and reintroduced. More control, but more complex.
---
Section 7: CRISPR: The Game Changer
CRISPR-Cas9 is a powerful gene-editing tool:
Cas9 cuts DNA.
Guide RNA directs it.
Fix: Cells repair the DNA by inserting/correcting it.
Benefits: Precision, speed, versatility.
---
Section 8: Real-World Impact
Gene therapy has shown success in:
SCID (Bubble Boy Disease)
Cystic Fibrosis, Sickle Cell Anemia, Hemophilia
CAR-T Cell Therapy for cancer
Luxturna for inherited blindness
Zolgensma for spinal muscular atrophy
---
Section 9: The Hurdles
Challenges include:
Immune response
Off-target effects
Vector safety
Long-term durability
High cost (e.g., Zolgensma costs over $2M)
---
Section 10: Beyond the Lab
Ethical issues:
Germline editing and its risks
“Designer babies” and societal inequality
Access and affordability
Informed consent and public perception
---
Section 11: What's Next?
Future directions:
Broader applications (heart disease, Alzheimer’s, HIV)
Advanced tools (base editing, prime editing)
Better vectors
Personalized treatments
---
Section 12: Conclusion
Gene therapy is a breakthrough that could transform medicine by treating diseases at their
genetic roots. While promising, it requires ongoing research, regulation, and ethical debate
to ensure its benefits reach all.
---
Section 13: References
National Human Genome Research Institute:
[Link]
American Society of Gene & Cell Therapy:
[Link]
Nature Biotechnology, Sheridan, C. (2020). Gene therapy prices start to fall.
Kurzgesagt – In a Nutshell: [Link]
Additional textbooks and reputable science news articles as referenced.
---
